Monoclonal Antibodies (MABs) such as the combination of Casirivimab/Imdevimab (CAT) are neutralizing antibodies against COVID-19.  MABs are the only treatment drug for COVID-19.  These drugs are offered at BCHCC.  When there is a virus in your body, like COVID-19, your immune system makes antibodies to fight it off.  But it takes time for your body to make antibodies for a new virus, and in the meantime you could get very sick.  This is where MABs come in.   MABs contain man-made antibodies that are similar to the antibodies of patients who recovered from COVID-19.  Scientists think that these antibodies may help limit the amount of virus in your body.  This could give your body more time to learn how to make its own antibodies.  MABs do not have any COVID-19 virus in them.  CAT also treats the new COIVD-19 variants.  Recently, this combination drug was approved to help prevent you from getting COVID-19 before you get sick if you are exposed and meet certain criteria.